logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Electric vehicle sales to accelerate following coronavirus pandemic

Roskill analyst Jose Lazuen tells Proactive London's Andrew Scott severe falls were expected in EV sales but that European and Chinese policies coupled with consumer preferences have shown them to remain strong. He adds that policy is going to favour and push EV sales in certain jurisdictions...

1 day, 22 hours ago

2 min read